In this retrospective cohort study of patients with non-resectable PC, we examined whether tumor-tissue expression of drug efflux pumps ABCB1 and ABCG2 was associated with outcome of chemotherapy with gemcitabine and nab-paclitaxel. This evidence concerns the gene ABCG2 and pachyonychia congenita.